#Japan #Tokyo #NMN #Kōraku #Supplement

Kōraku Biotechnology's Cutting-Edge NMN Supplement: KRK 18

Kōraku Biotechnology has officially launched a groundbreaking new supplement named KRK 18, which harnesses the unique combination of NMN (Nicotinamide Mononucleotide) and Lumbricus rubellus, a common earthworm known for its beneficial compounds. This innovative product is based on a patented formula currently under consideration by the Japan Patent Office (Patent Application No. 2025-095841) developed from significant research conducted at MIT.

The research team behind KRK 18 is headed by Dr. Athena Yang, a Ph.D. in biochemistry from the University of Tokyo, with impressive anti-aging research credentials from MIT. This partnership of traditional biological methodologies and cutting-edge scientific insights positions KRK 18 at the forefront of health supplements, illustrating Kōraku's commitment to reliability and innovation in health.

Patent Pending Composition

The patented formulation combines the synergistic effects of NMN and Lumbricus rubellus, focusing on enhancing overall health through several promising areas:

• - Balance of Lipids and Sugars: This aspect seeks to maintain optimal levels of fats and sugars within the body.
• - Support for Healthy Circulation: The formulation is designed to support a balanced circulatory environment, which is crucial for overall health and vitality.
• - Stress Management: Both internal and external stressors affect our well-being, and the composition aims to help regulate these rhythms, fostering overall stability.
• - Enhancement of Daily Performance: Daily performance can be influenced by many factors, and KRK 18 is designed to provide support in maintaining energy levels and productivity.

A Family-Driven Vision

The inception of Kōraku's health supplement line stems from a fundamental desire: the wish to promote health within families. The company's vision originated from the founder's strong personal aspirations for both his and others' families to live long, healthy lives. Particularly influenced by healthy lifestyle considerations stemming from his family’s dietary habits in the colder regions of Japan, Kōraku's journey towards creating quality supplements came from a desire to develop effective health solutions.

Future Directions

As Kōraku Biotechnology embarks on marketing KRK 18, there are plans in place to gather more clinical data from both domestic and international sources actively. By strengthening research through cellular studies, the company aims to back its products with robust scientific evidence, always returning to the original ethos behind its name: ensuring families can access products that enhance health. Looking towards the future, Kōraku aims to build a comprehensive health platform centered around its range of supplements, contributing to the well-being of individuals across generations.

About Kōraku Biotechnology

Kōraku Biotechnology is located in Chiyoda, Tokyo, and focuses on the development, manufacturing, and marketing of health supplements and natural foods. Established on June 12, 2024, the company is committed to leading innovation in health technology and creating a healthy and happy future for all.

For more information or inquiries about KRK 18 or other products, please reach out to:

• - Marketing Contact: Takahiro Abe
• - Email: [email protected]

Kōraku Biotechnology proudly exhibits its vision to lead with technology and innovation, contributing to the health and enjoyable lives of people globally.

Official Product Page

KRK 18 on Amazon

Disclaimer: The unique benefits of KRK 18 are based on ongoing research and are intended to support overall health and well-being. They are not guaranteed effects.